Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
复制标题
DOI:
10.1176/appi.ajp.2021.20081202
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Hasin DS
中科院分区:
文献类型:
--
作者:
Browne KC;Stohl M;Bohnert KM;Saxon AJ;Fink DS;Olfson M;Cerda M;Sherman S;Gradus JL;Martins SS;Hasin DS
To estimate the prevalence of past 12-month and lifetime cannabis use and cannabis use disorder among US veterans, describe demographic, substance use disorder, and psychiatric disorder correlates of non-medical cannabis use and cannabis use disorder, and explore differences in cannabis use and cannabis use disorder prevalence among veterans in states with and without medical marijuana laws. Participants were 3,119 respondents in the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) who identified as US veterans. Weighted prevalences were calculated. Logistic regressions tested associations of non-medical cannabis use and cannabis use disorder with demographic and clinical correlates and examined whether prevalence differed by state legalization status. The prevalence of any past 12-month cannabis use and cannabis use disorder was 7.3% and 1.8%, respectively. Lifetime prevalences were 32.5% and 5.7%, respectively. Past 12-month and lifetime cannabis use disorder prevalence estimates among non-medical cannabis users were 24.4% and 17.4%. Sociodemographic correlates of non-medical cannabis use and use disorder included younger age, male gender, being unmarried, lower income, and residing in a state with medical marijuana laws. Non-medical cannabis use and use disorder were associated with most psychiatric and substance use disorders examined. Among veterans, the odds of non-medical cannabis use and use disorder were increased among vulnerable subgroups, including those with lower income or psychiatric disorders and among participants in states with medical marijuana laws. Findings highlight the need for clinical attention (e.g., screening, assessment) and ongoing monitoring among veterans in the context of increasing legalization.
登录
查看更多内容
影响因子:
3.4
作者:
Bedard-Gilligan, Michele;Garcia, Natalia;Zoellner, Lori A;Feeny, Norah C
通讯作者:
Feeny, Norah C
影响因子:
4.4
作者:
Davis, Alan K.;Lin, Lewei A.;Bohnert, Kipling M.
通讯作者:
Bohnert, Kipling M.
影响因子:
17.7
作者:
Hasin, Deborah S.;Kerridge, Bradley T.;Grant, Bridget F.
通讯作者:
Grant, Bridget F.
影响因子:
5.3
作者:
Compton, WM;Conway, KP;Grant, BF
通讯作者:
Grant, BF
影响因子:
25.8
作者:
Grant BF;Goldstein RB;Saha TD;Chou SP;Jung J;Zhang H;Pickering RP;Ruan WJ;Smith SM;Huang B;Hasin DS
通讯作者:
Hasin DS